Clinical Trials Logo

Fractures, Compression clinical trials

View clinical trials related to Fractures, Compression.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05018637 Enrolling by invitation - Clinical trials for Osteoporotic Fractures

Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture

Start date: September 1, 2020
Phase: Phase 2
Study type: Interventional

Osteoporotic vertebral compression fractures (OVCFs) are serious health problems. Transplantation of mesenchymal stem cells (MSCs) has gained considerable attention to treat osteoporosis and OVCFs because implanted healthy MSCs could be differentiated into osteoblasts and reduce the susceptibility of fractures by facilitating new bone formation. This study compares teriparatide (PTH 1-34) injection to combined treatment with Wharton's jelly-derived MSCs (WJ-MSCs) and teriparatide (PTH 1-34) in patients with OVCFs. It is a randomized, open-label, phase 2 study.